Ling Mei

Title: Innovations by Inventor Ling Mei

Introduction

Ling Mei is a notable inventor based in Pasadena, CA, who has made significant contributions to the field of medical diagnostics and treatment. He holds three patents, showcasing his innovative approach to addressing complex health issues.

Latest Patents

One of Ling Mei's latest patents focuses on the diagnosis and treatment of inflammatory bowel disease (IBD), which includes Crohn's disease and Ulcerative Colitis. This invention provides methods for diagnosing, predicting susceptibility to, and treating IBD. In one embodiment, the method involves determining the presence or absence of genetic variants such as NOD2, TLR8, TLR2, CARD8, CARD15, and JAK3 to assess an individual's susceptibility and predict disease progression. Additionally, the invention includes methods for detecting specific antibodies, such as anti-Cbir1, anti-OmpC, ASCA, anti-I2, and pANCA, which further aid in diagnosis and treatment.

Career Highlights

Ling Mei is currently affiliated with Cedars-Sinai Medical Center, where he continues to advance his research and innovations in the medical field. His work has the potential to significantly improve the lives of individuals suffering from IBD.

Collaborations

Ling Mei collaborates with esteemed colleagues, including Stephan R. Targan and Marla C. Dubinsky, who contribute to the research and development of his innovative methods.

Conclusion

Ling Mei's contributions to the diagnosis and treatment of inflammatory bowel disease highlight his role as a leading inventor in the medical field. His innovative approaches are paving the way for improved patient outcomes and advancing medical science.